Colorado Leads released the following statement on SB23-271 regarding “Intoxicating Cannabinoid Hemp and Marijuana.” The bill prohibits intoxicating hemp-derived products from the Colorado market and clarifies that only marijuana and marijuana-derived products can be intoxicating. It allows for some hemp products to contain THC, with limits on potency, package size, and sales, which will be regulated by the Colorado Department of Public Health and Environment.

Statement from Chuck Smith, president of the board of directors for Colorado Leads:

“SB23-271 is a product of the stakeholder engagement process that characterizes Colorado’s cannabis policymaking process and has been critical to its success. It prohibits products that are potentially dangerous, while allowing for continued research and development of hemp-derived cannabinoids and products. Most importantly, it prioritizes product safety and regulatory compliance, which are cornerstones of the regulated cannabis industry. Creating a clear line between intoxicating and non-intoxicating products will ensure consumers know what they’re getting and how it will affect them. It will also prevent people under the age of 21 from accessing products with potentially intoxicating levels of THC.

“The regulation of intoxicating hemp-derived cannabinoids is a major policy issue that many states will be grappling with for years to come. By passing SB23-271, Colorado has once again established itself as a national leader on the complex issues facing the legal cannabis industry. In addition to setting an example for other states, it will help drive forward important conversations taking place at the federal level.”